385 related articles for article (PubMed ID: 22972807)
21. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer screening halves the risk of breast cancer death: a case-referent study.
Paap E; Verbeek AL; Botterweck AA; van Doorne-Nagtegaal HJ; Imhof-Tas M; de Koning HJ; Otto SJ; de Munck L; van der Steen A; Holland R; den Heeten GJ; Broeders MJ
Breast; 2014 Aug; 23(4):439-44. PubMed ID: 24713277
[TBL] [Abstract][Full Text] [Related]
23. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
24. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
25. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.
Paap E; Verbeek A; Puliti D; Broeders M; Paci E
J Med Screen; 2011; 18(3):142-6. PubMed ID: 22045823
[TBL] [Abstract][Full Text] [Related]
26. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
Zielonke N; Gini A; Jansen EEL; Anttila A; Segnan N; Ponti A; Veerus P; de Koning HJ; van Ravesteyn NT; Heijnsdijk EAM;
Eur J Cancer; 2020 Mar; 127():191-206. PubMed ID: 31932175
[TBL] [Abstract][Full Text] [Related]
27. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
Bell RJ
Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
[TBL] [Abstract][Full Text] [Related]
28. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Breast Cancer Mortality Trends Associated With Mammographic Screening and Adjuvant Therapy From 1986 to 2013 in the State of Victoria, Australia.
Burton R; Stevenson C
JAMA Netw Open; 2020 Jun; 3(6):e208249. PubMed ID: 32573707
[TBL] [Abstract][Full Text] [Related]
30. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
[TBL] [Abstract][Full Text] [Related]
31. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
[TBL] [Abstract][Full Text] [Related]
32. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.
van der Waal D; Broeders MJ; Verbeek AL; Duffy SW; Moss SM
Epidemiology; 2015 Jul; 26(4):590-6. PubMed ID: 25767987
[TBL] [Abstract][Full Text] [Related]
33. Benefits and harms of mammography screening.
Løberg M; Lousdal ML; Bretthauer M; Kalager M
Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer mortality after screening mammography in British Columbia women.
Coldman A; Phillips N; Warren L; Kan L
Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
[TBL] [Abstract][Full Text] [Related]
35. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
Sebuødegård S; Botteri E; Hofvind S
J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
[TBL] [Abstract][Full Text] [Related]
36. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
[TBL] [Abstract][Full Text] [Related]
37. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
[TBL] [Abstract][Full Text] [Related]
38. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
39. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
Hofvind S; Román M; Sebuødegård S; Falk RS
J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
